Jinling Pharmaceutical Co Ltd (000919) — Free Cash Flow Generation Index
Jinling Pharmaceutical Co Ltd (000919) has a Free Cash Flow Generation Index of 0.83x as of September 2025. Free cash flow of CN¥61.45 Million represents 1% of operating cash flow (CN¥74.01 Million). Read debt load of Jinling Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jinling Pharmaceutical Co Ltd Free Cash Flow Generation Index (1999–2024)
Historical FCF Generation Index trend for Jinling Pharmaceutical Co Ltd across 26 annual periods. Explore Jinling Pharmaceutical Co Ltd (000919) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year Free Cash Flow Generation Index for Jinling Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Jinling Pharmaceutical Co Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.31x | CN¥-47.44 Million | CN¥154.19 Million | CN¥201.63 Million | ▼ -89.1% |
| 2023 | -0.16x | CN¥-25.85 Million | CN¥158.92 Million | CN¥186.25 Million | ▲ +13.6% |
| 2022 | -0.19x | CN¥-49.05 Million | CN¥260.59 Million | CN¥309.64 Million | ▼ -142.5% |
| 2021 | 0.44x | CN¥129.26 Million | CN¥292.03 Million | CN¥162.76 Million | ▲ +587.4% |
| 2020 | 0.06x | CN¥20.06 Million | CN¥311.46 Million | CN¥291.41 Million | ▼ -91.2% |
| 2019 | 0.73x | CN¥340.13 Million | CN¥465.85 Million | CN¥125.71 Million | ▲ +6.5% |
| 2018 | 0.69x | CN¥297.41 Million | CN¥433.83 Million | CN¥136.42 Million | ▼ -19.3% |
| 2017 | 0.85x | CN¥376.31 Million | CN¥443.11 Million | CN¥66.80 Million | ▲ +822.4% |
| 2016 | -0.12x | CN¥-11.30 Million | CN¥96.15 Million | CN¥107.45 Million | ▼ -123.1% |
| 2015 | 0.51x | CN¥108.14 Million | CN¥212.45 Million | CN¥104.31 Million | ▼ -26.9% |
| 2014 | 0.70x | CN¥208.75 Million | CN¥299.89 Million | CN¥91.14 Million | ▲ +48.5% |
| 2013 | 0.47x | CN¥127.16 Million | CN¥271.21 Million | CN¥144.05 Million | ▲ +151.0% |
| 2012 | 0.19x | CN¥43.36 Million | CN¥232.12 Million | CN¥188.76 Million | ▼ -64.4% |
| 2011 | 0.52x | CN¥90.62 Million | CN¥172.82 Million | CN¥82.20 Million | ▲ +13.2% |
| 2010 | 0.46x | CN¥82.33 Million | CN¥177.81 Million | CN¥95.48 Million | ▼ -5.0% |
| 2009 | 0.49x | CN¥91.81 Million | CN¥188.41 Million | CN¥96.60 Million | ▼ -47.5% |
| 2008 | 0.93x | CN¥283.15 Million | CN¥305.26 Million | CN¥22.11 Million | ▲ +12.8% |
| 2007 | 0.82x | CN¥97.09 Million | CN¥118.06 Million | CN¥20.97 Million | ▼ -1.3% |
| 2006 | 0.83x | CN¥115.41 Million | CN¥138.50 Million | CN¥23.09 Million | ▲ +25.3% |
| 2005 | 0.67x | CN¥72.69 Million | CN¥109.29 Million | CN¥36.61 Million | ▲ +21.7% |
| 2004 | 0.55x | CN¥87.34 Million | CN¥159.81 Million | CN¥72.47 Million | ▼ -15.9% |
| 2003 | 0.65x | CN¥105.13 Million | CN¥161.86 Million | CN¥56.73 Million | ▲ +205.3% |
| 2002 | 0.21x | CN¥27.73 Million | CN¥130.36 Million | CN¥102.63 Million | ▲ +129.0% |
| 2001 | -0.73x | CN¥-67.78 Million | CN¥92.49 Million | CN¥160.27 Million | ▼ -275.1% |
| 2000 | 0.42x | CN¥96.81 Million | CN¥231.31 Million | CN¥134.49 Million | ▲ +152.3% |
| 1999 | -0.80x | CN¥-31.80 Million | CN¥39.77 Million | CN¥71.57 Million | — |